Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 3, Pages 597
Publisher
MDPI AG
Online
2021-03-09
DOI
10.3390/cells10030597
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A dual apolipoprotein C-II mimetic–apolipoprotein C-III antagonist peptide lowers plasma triglycerides
- (2020) Anna Wolska et al. Science Translational Medicine
- Incorporation of α-methylated amino acids into Apolipoprotein A-I mimetic peptides improves their helicity and cholesterol efflux potential
- (2020) Rafique Islam et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A novel apoA‐I mimetic peptide suppresses atherosclerosis by promoting physiological HDL function in apoE −/− mice
- (2020) Sanhu Gou et al. BRITISH JOURNAL OF PHARMACOLOGY
- Apolipoprotein C-II
- (2020) Anna Wolska et al. CURRENT OPINION IN LIPIDOLOGY
- Hypertriglyceridemia
- (2020) Anna Wolska et al. CURRENT OPINION IN LIPIDOLOGY
- The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
- (2020) Dustin Chernick et al. Biomolecules
- Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis
- (2020) Yun Chen et al. NEURON
- ABCA1 agonist mimetic peptide CS-6253 induces microparticles release from different cell types by ABCA1-efflux dependent mechanism
- (2019) Hafiane Anouar et al. CANADIAN JOURNAL OF CARDIOLOGY
- Infusions of large synthetic HDL containing trimeric apoA-I stabilize atherosclerotic plaques in hypercholesterolemic rabbits
- (2019) Cinzia Parolini et al. CANADIAN JOURNAL OF CARDIOLOGY
- The future of apolipoprotein E mimetic peptides in the prevention of cardiovascular disease
- (2019) Eftaxia-Konstantina Valanti et al. CURRENT OPINION IN LIPIDOLOGY
- Anti-atherosclerotic effects of an improved apolipoprotein A-I mimetic peptide
- (2019) Yasunori Suematsu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
- (2019) Joseph L. Witztum et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apolipoprotein C-II mimetic peptide is an efficient activator of lipoprotein lipase in human plasma as studied by a calorimetric approach
- (2019) Mart Reimund et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Advances in oral peptide therapeutics
- (2019) Daniel J. Drucker NATURE REVIEWS DRUG DISCOVERY
- Therapeutic peptides: Historical perspectives, current development trends, and future directions
- (2018) Jolene L. Lau et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study
- (2018) Matthew Budoff et al. CLINICAL CARDIOLOGY
- Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism
- (2018) Bastian Ramms et al. CURRENT OPINION IN LIPIDOLOGY
- Novel Fatty Acyl ApoE Mimetic Peptides Have Increased Potency To Reduce Plasma Cholesterol In Mice And Macaques
- (2018) Gattadahalli M Anantharamaiah et al. JOURNAL OF LIPID RESEARCH
- Reconstituted Discoidal High-Density Lipoproteins: Bioinspired Nanodiscs with Many Unexpected Applications
- (2018) Maki Tsujita et al. Current Atherosclerosis Reports
- Apoprotein E and Reverse Cholesterol Transport
- (2018) Godfrey Getz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease
- (2018) A.David Marais PATHOLOGY
- Intravenous toxicity and toxicokinetics of an HDL mimetic, Fx-5A peptide complex, in cynomolgus monkeys
- (2018) Mohammed Bourdi et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction
- (2018) C. Michael Gibson et al. AMERICAN HEART JOURNAL
- A consensus model of human apolipoprotein A-I in its monomeric and lipid-free state
- (2017) John T Melchior et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A consensus model of human apolipoprotein A-I in its monomeric and lipid-free state
- (2017) John T Melchior et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Self-Assembling Cyclic d,l-α-Peptides as Modulators of Plasma HDL Function. A Supramolecular Approach toward Antiatherosclerotic Agents
- (2017) Yannan Zhao et al. ACS Central Science
- Amphipathic polyproline peptides stimulate cholesterol efflux by the ABCA1 transporter
- (2016) D.O. Sviridov et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The 5A apolipoprotein A-I (apoA-I) mimetic peptide ameliorates experimental colitis by regulating monocyte infiltration
- (2016) Tobias M Nowacki et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Changing Face of HDL and the Best Way to Measure It
- (2016) Sotirios K. Karathanasis et al. CLINICAL CHEMISTRY
- Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Escalating Dose and Repeated Doses of CN-105 in Healthy Adult Subjects
- (2016) Jeffrey T. Guptill et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Lipoprotein lipase activity and interactions studied in human plasma by isothermal titration calorimetry
- (2016) Mart Reimund et al. JOURNAL OF LIPID RESEARCH
- Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
- (2016) Robert W. Mahley JOURNAL OF MOLECULAR MEDICINE-JMM
- Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation
- (2016) Ana Carolina P. Souza et al. KIDNEY INTERNATIONAL
- Neuroprotective pentapeptide CN-105 improves functional and histological outcomes in a murine model of intracerebral hemorrhage
- (2016) Beilei Lei et al. Scientific Reports
- Recent developments in modulating atherogenic lipoproteins
- (2015) C. Roger White et al. CURRENT OPINION IN LIPIDOLOGY
- A Pressure-dependent Model for the Regulation of Lipoprotein Lipase by Apolipoprotein C-II
- (2015) Nathan L. Meyers et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties
- (2015) Anna Schwendeman et al. JOURNAL OF LIPID RESEARCH
- Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro
- (2015) Anouar Hafiane et al. PLoS One
- CSL112 Enhances Biomarkers of Reverse Cholesterol Transport After Single and Multiple Infusions in Healthy Subjects
- (2014) Andreas Gille et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Apolipoprotein E derived HDL mimetic peptide ATI-5261 promotes nascent HDL formation and reverse cholesterol transport in vitro
- (2014) Anouar Hafiane et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Dysbetalipoproteinaemia: A mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E
- (2014) A. D. Marais et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Apolipoprotein A-I mimetics
- (2014) Srinivasa T. Reddy et al. CURRENT OPINION IN LIPIDOLOGY
- Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial
- (2014) J.-C. Tardif et al. EUROPEAN HEART JOURNAL
- Apolipoprotein E isoforms and lipoprotein metabolism
- (2014) Michael C. Phillips IUBMB LIFE
- Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review
- (2014) C. Roger White et al. JOURNAL OF LIPID RESEARCH
- Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins?
- (2014) N Vuilleumier et al. SWISS MEDICAL WEEKLY
- Novel Formulation of a Reconstituted High-Density Lipoprotein (CSL112) Dramatically Enhances ABCA1-Dependent Cholesterol Efflux
- (2013) Svetlana Diditchenko et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cationic peptide mR18L with lipid lowering properties inhibits LPS-induced systemic and liver inflammation in rats
- (2013) Oleg F. Sharifov et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans
- (2013) Jon C. Gonzales et al. JOURNAL OF CLINICAL INVESTIGATION
- Tomatoes, lysophosphatidic acid, and the small intestine: new pieces in the puzzle of apolipoprotein mimetic peptides?
- (2013) A. T. Remaley JOURNAL OF LIPID RESEARCH
- Polyproline-II Helix in Proteins: Structure and Function
- (2013) Alexei A. Adzhubei et al. JOURNAL OF MOLECULAR BIOLOGY
- FAMP, a Novel ApoA‐I Mimetic Peptide, Suppresses Aortic Plaque Formation Through Promotion of Biological HDL Function in ApoE‐Deficient Mice
- (2013) Yoshinari Uehara et al. Journal of the American Heart Association
- Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice
- (2012) Gaurav Nayyar et al. ATHEROSCLEROSIS
- Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice
- (2012) Shaila P. Handattu et al. ATHEROSCLEROSIS
- Cholesterol Efflux and Atheroprotection
- (2012) Robert S. Rosenson et al. CIRCULATION
- Reverse D4F, an Apolipoprotein-AI Mimetic Peptide, Inhibits Atherosclerosis in ApoE-null Mice
- (2012) Shucun Qin et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins
- (2011) Belinda A. Di Bartolo et al. ATHEROSCLEROSIS
- Antiatherogenic effects of newly developed apolipoprotein A-I mimetic peptide/phospholipid complexes against aortic plaque burden in Watanabe-heritable hyperlipidemic rabbits
- (2011) Atsushi Iwata et al. ATHEROSCLEROSIS
- Helix stabilization of amphipathic peptides by hydrocarbon stapling increases cholesterol efflux by the ABCA1 transporter
- (2011) D.O. Sviridov et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A new recombinant human apolipoprotein E mimetic peptide with high-density lipoprotein binding and function enhancing activity
- (2011) Wentao Zhao et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit
- (2011) Belinda A Di Bartolo et al. Lipids in Health and Disease
- Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions
- (2011) J. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 5A, an Apolipoprotein A-I Mimetic Peptide, Attenuates the Induction of House Dust Mite-Induced Asthma
- (2010) X. Yao et al. JOURNAL OF IMMUNOLOGY
- Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice
- (2010) Shaila P. Handattu et al. JOURNAL OF LIPID RESEARCH
- A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice
- (2010) John K. Bielicki et al. JOURNAL OF LIPID RESEARCH
- Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function
- (2010) Catherine E. Watson et al. JOURNAL OF LIPID RESEARCH
- 5A Apolipoprotein Mimetic Peptide Promotes Cholesterol Efflux and Reduces Atherosclerosis in Mice
- (2010) M. J. A. Amar et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The 5A Apolipoprotein A-I Mimetic Peptide Displays Antiinflammatory and Antioxidant Properties In Vivo and In Vitro
- (2009) Fatiha Tabet et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Proteomics of Apolipoproteins and Associated Proteins From Plasma High-Density Lipoproteins
- (2009) Pia Davidsson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH2
- (2009) Geeta Datta et al. ATHEROSCLEROSIS
- Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease
- (2009) Shaila P. Handattu et al. NEUROBIOLOGY OF DISEASE
- Prevention of Hepatic Fibrosis in a Murine Model of Metabolic Syndrome with Nonalcoholic Steatohepatitis
- (2008) Laurie D. DeLeve et al. AMERICAN JOURNAL OF PATHOLOGY
- Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis
- (2008) Christina Charles-Schoeman et al. CLINICAL IMMUNOLOGY
- Asymmetry in the Lipid Affinity of Bihelical Amphipathic Peptides
- (2008) Amar A. Sethi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effect of Leucine to Phenylalanine Substitution on the Nonpolar Face of a Class A Amphipathic Helical Peptide on Its Interaction with Lipid
- (2008) Vinod K. Mishra et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice
- (2008) Stephen J. Peterson et al. JOURNAL OF LIPID RESEARCH
- Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
- (2008) LeAnne T. Bloedon et al. JOURNAL OF LIPID RESEARCH
- Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS
- (2008) Robert W. Mahley et al. JOURNAL OF LIPID RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More